Bullish & Foolish
Full INDP fundamentals All 466 on the Survival Watch

INDPIndaptus Therapeutics, Inc.

Is Indaptus Therapeutics struggling financially?

Yes, by its own account. Indaptus Therapeutics told the SEC on 15 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

7/100

Critical

Sector
Biotech/Pharma
Market cap
$171.9M
Source filing
10-Q 15 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 3months

    If the burn speeds up

    Empty by Sep 2026

  • 6months

    If it eases off

    Empty by Dec 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$11.6M

÷

Cash burned over the last 12 months

$30.8M

What Indaptus Therapeutics told the SEC

…profitable, do not expect to become profitable in the near future and may never become profitable. We have identified conditions and events that raise substantial doubt regarding our ability to continue as going concern. Given our lack of current cash flow, we will need to raise additional capital. If we are unable to raise a sufficient amount of capital when needed on acceptable terms or at all, we…

Indaptus Therapeutics, Inc., Form 10-Q, filed 15 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 11782.8% share-count increase The company issued stock. Each share now owns 99.2% less of the business than a year ago, before any change in the price.
  • Cash burn is increasing It is spending 16% more cash per year than it was, so the runway above shortens even if nothing else changes.

Other Biotech/Pharma companies that filed the doubt